60 related articles for article (PubMed ID: 1645756)
1. Bistable insulin response: The win-win solution for glycemic control.
Akhtar J; Han Y; Han S; Lin W; Cao C; Ge R; Babarinde IA; Jia Q; Yuan Y; Chen G; Zhao Y; Ye R; Liu G; Chen L; Wang G
iScience; 2022 Dec; 25(12):105561. PubMed ID: 36465102
[TBL] [Abstract][Full Text] [Related]
2. Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.
Haahr H; Heise T
Clin Pharmacokinet; 2020 Feb; 59(2):155-172. PubMed ID: 31667789
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.
Heise T; Stender-Petersen K; Hövelmann U; Jacobsen JB; Nosek L; Zijlstra E; Haahr H
Clin Pharmacokinet; 2017 Jun; 56(6):649-660. PubMed ID: 27878566
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Fcγ Receptor IIB Activation Blunts Insulin Delivery to Skeletal Muscle to Cause Insulin Resistance in Mice.
Tanigaki K; Chambliss KL; Yuhanna IS; Sacharidou A; Ahmed M; Atochin DN; Huang PL; Shaul PW; Mineo C
Diabetes; 2016 Jul; 65(7):1996-2005. PubMed ID: 27207525
[TBL] [Abstract][Full Text] [Related]
5. Insulin entry into muscle involves a saturable process in the vascular endothelium.
Majumdar S; Genders AJ; Inyard AC; Frison V; Barrett EJ
Diabetologia; 2012 Feb; 55(2):450-6. PubMed ID: 22002008
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs.
Miles PD; Li S; Hart M; Romeo O; Cheng J; Cohen A; Raafat K; Moossa AR; Olefsky JM
J Clin Invest; 1998 Jan; 101(1):202-11. PubMed ID: 9421483
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM.
Sato T; Asahi Y; Toide K; Nakayama N
Diabetologia; 1995 Sep; 38(9):1033-41. PubMed ID: 8591816
[TBL] [Abstract][Full Text] [Related]
8. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Handberg A; Vaag A; Vinten J; Beck-Nielsen H
Diabetologia; 1993 Jul; 36(7):668-74. PubMed ID: 8395436
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the lack of spare high-affinity insulin receptors in skeletal muscle.
Camps M; Gumà A; Viñals F; Testar X; Palacín M; Zorzano A
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):993-9. PubMed ID: 1323279
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.
Bak JF
Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433
[TBL] [Abstract][Full Text] [Related]
11. What is the role of the insulin receptor tyrosine kinase?
Espinal J
Trends Biochem Sci; 1988 Oct; 13(10):367-8. PubMed ID: 3072695
[No Abstract] [Full Text] [Related]
12. In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.
Freidenberg GR; Suter SL; Henry RR; Reichart D; Olefsky JM
J Clin Invest; 1991 Jun; 87(6):2222-9. PubMed ID: 1645756
[TBL] [Abstract][Full Text] [Related]
13. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity.
Nolan JJ; Freidenberg G; Henry R; Reichart D; Olefsky JM
J Clin Endocrinol Metab; 1994 Feb; 78(2):471-7. PubMed ID: 8106637
[TBL] [Abstract][Full Text] [Related]
14. Delayed onset of insulin activation of the insulin receptor kinase in vivo in human skeletal muscle.
Freidenberg GR; Suter S; Henry RR; Nolan J; Reichart D; Olefsky JM
Diabetes; 1994 Jan; 43(1):118-26. PubMed ID: 8262308
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase activity of skeletal muscle during insulin infusion in humans.
Nyomba BL; Ossowski VM; Saad MF; Bogardus C; Mott DM
J Clin Endocrinol Metab; 1992 Jul; 75(1):218-23. PubMed ID: 1619013
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
